QuantumSi is trading 11.21% up at $1.19, versus its September 30 regular-session close of $1.07, after interim results showed Proteus outperformed Platinum Pro on alignments, peptide identification and protein detection. - Results are preliminary; Proteus remains in development, is not fully optimized, with commercial launch targeted for Q2 2027. - Published September 28 ahead of World HUPO presentation, results were public before September 30; supplied closes rose September 29 and 30. No after-hours volume data was provided.